05.01.06
BioGaia Signs Agreements with Forest Laboratories & Ferring Pharmaceuticals
BioGaia AB, Stockholm, Sweden, has signed an agreement with the British pharmaceutical company Forest Laboratories UK Limited. The agreement gives Forest the exclusive rights to sell BioGaia’s Reuteri Drops in Great Britain and Ireland. BioGaia has also entered into an agreement with the Swiss company Ferring Pharmaceuticals allowing the company exclusive rights to sell the Reuteri Drops in Spain, Portugal, Czech Republic and Hungary, plus optional rights to sell in several other countries. BioGaia’s patented Reuteri Drops are a simple, safe and effective way to improve the digestive health of infants.
BioGaia AB, Stockholm, Sweden, has signed an agreement with the British pharmaceutical company Forest Laboratories UK Limited. The agreement gives Forest the exclusive rights to sell BioGaia’s Reuteri Drops in Great Britain and Ireland. BioGaia has also entered into an agreement with the Swiss company Ferring Pharmaceuticals allowing the company exclusive rights to sell the Reuteri Drops in Spain, Portugal, Czech Republic and Hungary, plus optional rights to sell in several other countries. BioGaia’s patented Reuteri Drops are a simple, safe and effective way to improve the digestive health of infants.